MktsMarkets

Cocrystal Pharma, Inc.
NASDAQ: COCPKey statistics
COCP News
Stories mentioning COCP from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 225.00 | |||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||||
| Research & Development | 1,371 | 1,619 | 954.00 | 1,122 | 1,360 | 2,037 | 3,242 | 4,308 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 2,581 | 2,481 | 2,089 | 2,108 | 2,341 | 3,230 | 5,042 | 5,448 |
| Operating Income (Loss) | (2,356) | (2,481) | (2,089) | (2,108) | (2,341) | (3,230) | (5,042) | (5,448) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | |||||||
| Net Income (Loss) | (2,299) | (2,426) | (2,049) | (2,055) | (2,301) | (3,266) | (4,939) | (5,343) |
| Earnings Per Share (Basic) | (0.17) | (0.21) | (0.19) | (0.20) | (0.23) | (0.32) | (0.49) | (0.53) |
| Earnings Per Share (Diluted) | (0.17) | (0.21) | (0.19) | (0.20) | (0.23) | (0.32) | (0.49) | (0.53) |
| Weighted Average Shares Outstanding (Basic) | 13,786 | 11,290 | 10,991 | 10,174 | 10,174 | 10,174 | 10,174 | 10,174 |
| Weighted Average Shares Outstanding (Diluted) | 13,786 | 11,290 | 10,991 | 10,174 | 10,174 | 10,174 | 10,174 | 10,174 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About COCP
Cocrystal Pharma, Inc. (NASDAQ: COCP) is a stock listed on the Nasdaq Stock Market under the ticker symbol COCP. It last traded at $0.9700 (Oct 26, 2026, 2:14 PM ET), up 2.2% on the day. That gives Cocrystal Pharma a market capitalisation of $18.3M.
Over the past 52 weeks COCP has traded between $0.7600 and $2.03.
Revenue for the quarter ended Mar 31, 2026 was $225.0K; a net loss of $2.3M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $225.0K | -$2.3M | -1021.8% |
| Dec 31, 2025 | — | -$2.4M | — |
| Sep 30, 2025 | — | -$2.0M | — |
| Jun 30, 2025 | — | -$2.1M | — |
From Cocrystal Pharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…